{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:18:29Z","timestamp":1791908309514,"version":"4.3.4"},"reference-count":57,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","award":["PPRG15-10"],"award-info":[{"award-number":["PPRG15-10"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006630","name":"Lung Foundation Australia","doi-asserted-by":"publisher","award":["Bill van Nierop PhD Scholarship"],"award-info":[{"award-number":["Bill van Nierop PhD Scholarship"]}],"id":[{"id":"10.13039\/501100006630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1067511"],"award-info":[{"award-number":["1067511"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127337"],"award-info":[{"award-number":["1127337"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,5,16]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>\n                    Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease associated with chronic inflammation and tissue remodelling leading to fibrosis, reduced pulmonary function, respiratory failure and death. Bleomycin (Blm)-induced lung fibrosis in mice replicates several clinical features of human IPF, including prominent lymphoid aggregates of predominantly B-cells that accumulate in the lung adjacent to areas of active fibrosis. We have shown previously a requirement for B-cells in the development of Blm-induced lung fibrosis in mice. To determine the therapeutic potential of inhibiting B-cell function in pulmonary fibrosis, we examined the effects of anti-CD20 B-cell ablation therapy to selectively remove mature B-cells from the immune system and inhibit Blm-induced lung fibrosis. Anti-CD20 B-cell ablation did not reduce fibrosis in this model; however, immune phenotyping of peripheral blood and lung resident cells revealed that anti-CD20-treated mice retained a high frequency of CD19\n                    <jats:sup>+<\/jats:sup>\n                    CD138\n                    <jats:sup>+<\/jats:sup>\n                    plasma cells. Interestingly, high levels of CD138\n                    <jats:sup>+<\/jats:sup>\n                    cells were also identified in the lung tissue of patients with IPF, consistent with the mouse model. Treatment of mice with bortezomib, which depletes plasma cells, reduced the level of Blm-induced lung fibrosis, implicating plasma cells as important effector cells in the development and progression of pulmonary fibrosis.\n                  <\/jats:p>","DOI":"10.1183\/13993003.01469-2021","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:15:31Z","timestamp":1657181731000},"page":"2101469","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis"],"prefix":"10.1183","volume":"60","author":[{"given":"Cecilia M.","family":"Pr\u00eale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tylah","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-2924","authenticated-orcid":false,"given":"David R.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Grainge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Baltic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-1177","authenticated-orcid":false,"given":"Matthias","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey J.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4064-6127","authenticated-orcid":false,"given":"Darryl A.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Hoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"McAnulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Mutsaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"2024102102590978000_60.5.2101469.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705751"},{"key":"2024102102590978000_60.5.2101469.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0674OC"},{"key":"2024102102590978000_60.5.2101469.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30866-8"},{"key":"2024102102590978000_60.5.2101469.4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12931-019-1195-7","article-title":"Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis","volume":"20","author":"Heukels","year":"2019","journal-title":"Respir Res"},{"key":"2024102102590978000_60.5.2101469.5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/icb.2017.22","article-title":"Idiopathic pulmonary fibrosis and a role for autoimmunity","volume":"95","author":"Hoyne","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"2024102102590978000_60.5.2101469.6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.5735"},{"key":"2024102102590978000_60.5.2101469.7","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S40673"},{"key":"2024102102590978000_60.5.2101469.8","doi-asserted-by":"publisher","DOI":"10.1007\/s004080000020"},{"key":"2024102102590978000_60.5.2101469.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.23667"},{"key":"2024102102590978000_60.5.2101469.10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006998"},{"key":"2024102102590978000_60.5.2101469.11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000284"},{"key":"2024102102590978000_60.5.2101469.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61079-4"},{"key":"2024102102590978000_60.5.2101469.13","first-page":"2044","article-title":"Serological implications of germinal center-like structures in primary Sj\u00f6gren's syndrome","volume":"34","author":"Jonsson","year":"2007","journal-title":"J Rheumatol"},{"key":"2024102102590978000_60.5.2101469.14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/1346-8138.14498","article-title":"Analysis of possible structures of inducible skin-associated lymphoid tissue in lupus erythematosus profundus","volume":"45","author":"Kogame","year":"2018","journal-title":"J Dermatol"},{"key":"2024102102590978000_60.5.2101469.15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.1072"},{"key":"2024102102590978000_60.5.2101469.16","doi-asserted-by":"publisher","DOI":"10.1002\/path.916"},{"key":"2024102102590978000_60.5.2101469.17","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.3.218"},{"key":"2024102102590978000_60.5.2101469.18","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2965"},{"key":"2024102102590978000_60.5.2101469.19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.20"},{"key":"2024102102590978000_60.5.2101469.20","doi-asserted-by":"publisher","DOI":"10.1038\/nri1572"},{"key":"2024102102590978000_60.5.2101469.21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/TP.0000000000002594","article-title":"Memory B cells and long-lived plasma cells","volume":"103","author":"Ionescu","year":"2019","journal-title":"Transplantation"},{"key":"2024102102590978000_60.5.2101469.22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795"},{"key":"2024102102590978000_60.5.2101469.23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.3.485"},{"key":"2024102102590978000_60.5.2101469.24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.6.813"},{"key":"2024102102590978000_60.5.2101469.25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064833"},{"key":"2024102102590978000_60.5.2101469.26","doi-asserted-by":"publisher","DOI":"10.1038\/nri2849"},{"key":"2024102102590978000_60.5.2101469.27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1317"},{"key":"2024102102590978000_60.5.2101469.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.07.045"},{"key":"2024102102590978000_60.5.2101469.29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091472"},{"key":"2024102102590978000_60.5.2101469.30","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100604"},{"key":"2024102102590978000_60.5.2101469.31","doi-asserted-by":"publisher","DOI":"10.1513\/pats.201201-007AW"},{"key":"2024102102590978000_60.5.2101469.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00182412"},{"key":"2024102102590978000_60.5.2101469.33","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.18.5.2898"},{"key":"2024102102590978000_60.5.2101469.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.23995"},{"key":"2024102102590978000_60.5.2101469.35","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.060205"},{"key":"2024102102590978000_60.5.2101469.36","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1291-2"},{"key":"2024102102590978000_60.5.2101469.37","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.21037\/apm-21-2676","article-title":"Analysis of immune-related genes in idiopathic pulmonary fibrosis based on bioinformatics and experimental verification","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2024102102590978000_60.5.2101469.38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203476"},{"key":"2024102102590978000_60.5.2101469.39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201611-2263OC"},{"key":"2024102102590978000_60.5.2101469.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025392"},{"key":"2024102102590978000_60.5.2101469.41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1983"},{"key":"2024102102590978000_60.5.2101469.42","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.101"},{"key":"2024102102590978000_60.5.2101469.43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.361"},{"key":"2024102102590978000_60.5.2101469.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"2024102102590978000_60.5.2101469.45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.semarthrit.2016.10.003","article-title":"A multicenter, open-label, comparative study of B-cell depletion therapy with rituximab for systemic sclerosis-associated interstitial lung disease","volume":"46","author":"Daoussis","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2024102102590978000_60.5.2101469.46","doi-asserted-by":"crossref","first-page":"e0127771","DOI":"10.1371\/journal.pone.0127771","article-title":"Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis","volume":"10","author":"Donahoe","year":"2015","journal-title":"PLoS One"},{"key":"2024102102590978000_60.5.2101469.47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214816"},{"key":"2024102102590978000_60.5.2101469.48","doi-asserted-by":"publisher","DOI":"10.1002\/art.11181"},{"key":"2024102102590978000_60.5.2101469.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003032"},{"key":"2024102102590978000_60.5.2101469.50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107292"},{"key":"2024102102590978000_60.5.2101469.51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/imj.14886","article-title":"Bortezomib use and outcomes for the treatment of multiple myeloma","volume":"50","author":"Loke","year":"2020","journal-title":"Intern Med J"},{"key":"2024102102590978000_60.5.2101469.52","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.2006.2.3.271"},{"key":"2024102102590978000_60.5.2101469.53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3531"},{"key":"2024102102590978000_60.5.2101469.54","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.3390\/ijms222111595","article-title":"Proteasome inhibitors and their pharmacokinetics, pharmacodynamics, and metabolism","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024102102590978000_60.5.2101469.55","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10787-021-00863-2","article-title":"Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases","volume":"29","author":"Khalesi","year":"2021","journal-title":"Inflammopharmacology"},{"key":"2024102102590978000_60.5.2101469.56","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-200717"},{"key":"2024102102590978000_60.5.2101469.57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1165\/rcmb.2021-0112OC","article-title":"Bortezomib inhibits lung fibrosis and fibroblast activation without proteasome inhibition","volume":"66","author":"Penke","year":"2022","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01469-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:08:10Z","timestamp":1740362890000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01469-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,11,24]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1183\/13993003.01469-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01469-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}